Biotechnology | Healthcare
Concord Biotech Limited, a biopharma company, engages in the research and development, manufacturing, marketing, and sale of pharmaceutical products in India and internationally. The company provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. It also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, and pimecrolimus for immunosuppressants therapeutic segment; temsirolimus, everolimus, romidepsin, mitomycin, midostaurin, dactinomycin, staurosporin, mitoguazone, and everolimus premix for oncology therapeutic segment; mupirocin, mupirocin calcium, polymyxin B sulfate, fidaxomicin, vancomycin hydrochloride, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi, micafungin sodium, amphotericin B, and nystatin for anti-fungal therapeutic segment; and lovastatin, pravastatin sodium, and enzymes for other applications. In addition, it provides contract research and manufacturing services in the areas of fermentation and semi-synthesis products. Concord Biotech Limited was incorporated in 1984 and is based in Ahmedabad, India.
Market Cap
221325623296
Current Price
2115.6
52 Week Range
1345.0 - 2664.0
Previous Close
2099.7
Open
2109.0
Industry
Biotechnology
Sector
Healthcare
Address
16th Floor, B-Wing, Mondeal Heights Iscon Cross Road S.G. Highway, Ahmedabad, 380015, India
Phone
+91-79681-38700
Fax
+91-27142-22504
Website
https://www.concordbiotech.com
Day Low
2099.7
Day High
2135.5
Dividend Yield
0.43
PE Ratio
57.255753
Earnings Per Share
36.95
Beta
EBITDA
5063314944
Book Value
173.283
EPS
43.8
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Sudhir Jairam Vaid | Chairman & MD | 72 | 1952 |
Mr. Ankur Vaid | Joint MD, CEO & Director | 42 | 1982 |
Mr. Lalit Sethi | Chief Financial Officer | - | - |
Ms. Hina Patel | Company Secretary & Compliance Officer | - | - |
Mr. Devang Bhatt | VP of Sales & Marketing and Head of Limbasi Plant-3 | - | - |
Mr. Manoj Kumar | VP of Formulation Division & Head of Valthera Unit-2 | - | - |
Sundeep Bengani | General Manager, International Business Development | - | - |
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.